For many pharma and biotech organizations, personalization is already in motion—but achieving real business impact requires moving beyond engagement metrics. The true value of personalization lies in the robust infrastructure it creates, aligning cases, data, and technology to enable scalable and repeatable success.

In this 60-minute live webinar, senior leaders from Novo Nordisk, AstraZeneca, Boehringer Ingelheim and Point B will go beyond the why and dives into the how. Learn from the pioneering minds as they share practical examples of personalization strategies, where they’ve seen failures, success, and the biggest challenges to watch out for. Hear real-world case studies demonstrating how pharma have leveraged data, AI, and automation to drive measurable outcomes—such as improving HCP engagement, optimizing content strategies, and increasing commercial impact.

Whether you are just beginning or refining an existing strategy, this discussion will help you identify high-impact starting points, best practices for experimentation, and the long-term benefits of building a personalization framework.

Key Learning Points including:

1. Unlocking the True Value of Personalization:
         -    Understand personalization beyond engagement or top-line results. Learn how it builds the essential infrastructure needed to align use cases, data, and technology for sustained success.
2. Practical Approaches—From Start to Scale:
           -   Discover how small, repeatable personalization initiatives can help your organization identify challenges, refine strategies, and develop scalable frameworks.
3.  Aligning Your Organization for Omnichannel Success:
            -  Learn how to dismantle internal silos and foster cross-functional collaboration between marketing, medical, sales, and regulatory teams to achieve personalization success.
4. Field Lessons—Successes, Challenges, and Future Directions:
           -  Gain insights from real-world examples shared by pharma leaders. Understand what works, what doesn’t, and how to evolve towards an ideal personalization model.